Avant Diagnostics Inc. | |
Stock Exchange | Other OTC |
EPS |
- |
Market Cap |
$9.43 M |
Shares Outstanding |
336.96 M |
Public Float |
321.6 M |
Address |
1050 30th Street NW Washington District of Columbia 20007 United States |
Employees | - |
Website | http://www.avantdiagnostics.com |
Updated | 09/14/2018 |
Avant Diagnostics, Inc. is a medical technology company, which engages in the research of human genome sequencing project. It also develops the OvaDx screening test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. The company is headquartered in Scottsdale, AZ. |